Ignite Creation Date:
2024-05-06 @ 12:41 PM
Last Modification Date:
2024-10-26 @ 1:03 PM
Study NCT ID:
NCT03827525
Status:
UNKNOWN
Last Update Posted:
2019-10-18
First Post:
2019-01-29
Brief Title:
Cognitive and Behavioral Therapy of Anxiety in Williams Syndrome
Sponsor:
University Hospital Montpellier
Organization:
University Hospital Montpellier
Study Overview
Official Title:
Cognitive and Behavioral Therapy of Anxiety in Williams Syndrome
Status:
UNKNOWN
Status Verified Date:
2019-01
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
WILL-COPE
Brief Summary:
Patients with Williams-Beuren syndrome are eight times more likely to suffer from anxiety compared to the general population Few therapeutic solutions are proposed to these patients The objective of this research is to validate a cognitive and behavioral therapy anxiety protocol for patients with this syndrome
Detailed Description:
Most studies agree that anxiety disorders are more frequent in people with intellectual disabilities that in the general population Williams syndrome WS is a rare disease associated with an anxiety rate 8 times higher than in the general population The therapeutic solutions proposed in this population remain limited in particular concerning approaches without the use of medication The objective of the study is to evaluate the effectiveness of a program of Cognitive and Behavioral Therapies CBT in Williams Syndrome WS For this an ABA-type protocol will be used It consists of evaluating the effectiveness of an interventional program longitudinally using a single case type study Adults patients with WS and suffering from anxiety will be recruited They will be enrolled in a program consisting in nine sessions of a psychotherapy program targeting anxiety There will be a pretherapy visit day 0 nine sessions of psychotherapy month 0 to month 5 and a visit 3 month after the end of the therapy at month 8 the visit of the end of the research V10 The expected results will be to validate a psychotherapeutic program for patients with WS suffering of anxiety This program might be extended to other patients with intellectual disability
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None